Cempra Inc (CEMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
26 Pages - GLDATA62532
$250.00

Summary

Cempra Inc (Cempra) formerly Cempra Holdings, LLC is a pharmaceutical company that develops antibacterials to the critical medical needs. The company offers products such as solithromycin and fusidic acid. It provides solithromycin which is a next-generation oral and intravenous fluoroketolide. Cempra offers fusidic acid which is active against gram-positive organisms including MRSA. The company provides macrolides which are antimicrobial drugs that are active against aerobic and anaerobic gram-positive cocci and are prescribed for the treatment of respiratory tract and soft tissue infection. Cempra is headquartered in Chapel Hill, North Carolina, the US.

Cempra Inc (CEMP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cempra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cempra Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cempra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cempra Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cempra Pharma Secures US$5 Million In Venture Financing 11
Licensing Agreements 11
Cempra Enters Into Licensing And Development Agreement With Toyama Chemical For Solithromycin 11
Equity Offering 12
Cempra Raises USD100 Million in Public Offering Shares 12
Cempra Raises USD148 Million in Public Offering of Shares 14
Cempra to Raise USD50 Million in Public Offering of Common Stock 16
Cempra Files Registration Statement For Public Offering Of Securities For US$100 Million 17
Cempra Announces Private Placement Of Shares For US$25 Million 18
Cempra Completes Public Offering Of Shares For US$58 Million 18
Cempra Completes Private Placement Of Shares For US$25 Million 20
Cempra Holdings Completes Exercise Of Underwriter’s Option For IPO For US$58 Million 21
Cempra Inc - Key Competitors 23
Key Employees 24
Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cempra Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cempra Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cempra Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Cempra Inc, Medical Devices Deals, 2011 to YTD 2017 9
Cempra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cempra Pharma Secures US$5 Million In Venture Financing 11
Cempra Enters Into Licensing And Development Agreement With Toyama Chemical For Solithromycin 11
Cempra Raises USD100 Million in Public Offering Shares 12
Cempra Raises USD148 Million in Public Offering of Shares 14
Cempra to Raise USD50 Million in Public Offering of Common Stock 16
Cempra Files Registration Statement For Public Offering Of Securities For US$100 Million 17
Cempra Announces Private Placement Of Shares For US$25 Million 18
Cempra Completes Public Offering Of Shares For US$58 Million 18
Cempra Completes Private Placement Of Shares For US$25 Million 20
Cempra Holdings Completes Exercise Of Underwriter’s Option For IPO For US$58 Million 21
Cempra Inc, Key Competitors 23
Cempra Inc, Key Employees 24
Cempra Inc, Subsidiaries 25

List of Figures
Cempra Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cempra Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cempra Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cempra Inc, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838